Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization).
Market Growth and Revenue Estimation:
1. Increasing Demand for Biopharmaceuticals
2. Increasing R&D Expenditure in Biopharmaceutical Companies
Market Revenue Growth:The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930
Detailed Market Growth Analysis:
Based on application, the downstream processing market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. In 2016, the vaccine production segment accounted for the largest share of the market. Technological advancement in the downstream purification technology to develop high-quality products such as Vaccines at lower costs is expected to drive the growth of this segment.
Based on technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.
Regional Growth Analysis:
The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. On the other hand, the high cost of instruments and the need for skilled professionals are expected to restrain the growth of this market to a certain extent during the forecast period. In addition, purification bottleneck, lack of single-use options, and dearth of skilled professionals are the major challenges in the downstream processing market
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=73180930
Key Players:
The market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).
